Three popular asthma drugs could be pulled off the market.
The drugs Advair, Serevent and Foradil are all under scrutiny by a gathering of asthma experts. That, because some asthma patients have reported the medications made their asthma worse when they had an attack. In fact, at least a dozen deaths have been linked to these drugs.
So, now that panel is considering whether the drugs should be relabled or pulled from the market altogether.